Beijing Tongren Hospital, Capital Medical University

What Beijing Tongren Hospital, Capital Medical University does

Beijing Tongren Hospital, Capital Medical University is a Grade A tertiary (三甲) public hospital founded in 1886, making it one of the oldest continuously operating hospitals in China. It specializes in ophthalmology and otolaryngology, both designated as Ministry of Education national key disciplines, and operates two campuses in Beijing: the main Chongwenmen campus and the Yizhuang campus. The hospital employs 4,200+ staff, maintains 1,759 approved beds, and runs 76 clinical and medical technology departments spanning the full range of medical specialties, with three dedicated research institutes for ophthalmology, ENT, and diabetes. It is ranked A+ in the national public hospital performance evaluation and serves as the WHO Ear and Hearing Health Cooperation Center, National ENT Quality Control Center, and Beijing Eye Quality Control Center.

The hospital's business model is anchored in government-regulated public healthcare service delivery, generating revenue through outpatient consultations, inpatient care, surgeries, diagnostics, and specialized treatments across its core specialties. Its wholly-owned commercial subsidiary, Beijing Tongren Medical Technology (同仁科技), operates 18 directly-managed optical retail stores in Beijing under the Tongren Optometry brand, generating 500M+ yuan in annual revenue and processing 400,000+ eye examinations. Technology and IP differentiation is substantial: the hospital holds 43 patents (17 invention), has 19 patents transferred/licensed, developed the proprietary glaucoma micro-invasive internal drainage surgery technique now adopted in 70% of national procedures, and achieved NMPA approval in February 2025 for Stapokibart (司普奇拜单抗), the world's first IL-4Rα monoclonal antibody for seasonal allergic rhinitis. Its AI-assisted eye disease screening model, developed from population-based studies, supports early detection of blinding diseases.

Go-to-market operates through direct patient access (WeChat and 114 platform appointment booking, walk-in, and referral networks), medical alliance partnerships extending into Hebei, and an academic/clinical talent network that concentrates 1 CAE Academician, multiple Changjiang Scholars, and State Council Special Allowance experts. The hospital monetizes through government-regulated healthcare pricing, optical hardware sales, professional education and training programs, and is now extending into proprietary biologic therapeutics commercialization and smart hospital infrastructure (notably the 2025 China Unicom partnership for 5G and IoT-enabled intelligent wards).

Name

Beijing Tongren Hospital, Capital Medical University

Legal name

首都医科大学附属北京同仁医院

Website

https://bjtrhos.cn

Company type

Private

Founded year

1886

Operating status

Operating

Short description

Beijing Tongren Hospital is a 140-year-old Grade A tertiary public hospital in Beijing specializing in ophthalmology and otolaryngology, serving the general public across 76 departments, two campuses, and 1,759 beds while commercializing proprietary surgical techniques, the Stapokibart biologic, and an 18-store optical retail network.

Ownership category

akta.pro rank

Product category

Tertiary Specialty Hospital Services

NAICS

General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Ophthalmic Specialty Hospitals (HLAFAHAJ)

akta.pro secondary industry

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA)

Keywords

• Ophthalmology services
• Otolaryngology services
• Tertiary hospital care
• Allergy treatment
• Eye disease surgery

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Revenue model

1. Medical Services Revenue: Beijing Tongren Hospital generates revenue primarily through comprehensive medical services including outpatient consultations, inpatient care, surgeries, diagnostic tests, and specialized treatments across 76 clinical and medical technology departments.
2. Optometry and Eyewear (同仁验光配镜): Subsidiary company Beijing Tongren Medical Technology operates 18 optical retail stores in Beijing providing optometry, eyeglass fitting, hearing aid services, and eye health management. Annual revenue exceeds 500 million yuan with approximately 400,000 eye examinations annually.
3. Continuing Education and Training: Hospital provides medical education and professional training programs, including continuing medical education for physicians and nurses, international exchange programs, and specialized training workshops.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Beijing Tongren Hospital is a Class A tertiary public hospital providing comprehensive medical services with national-level specialties in ophthalmology and otolaryngology. It operates 76 clinical and medical technology departments across two campuses (Chongwenmen and Yizhuang) with 1,759 approved beds, delivering outpatient consultations, inpatient care, surgeries, diagnostics, and specialized treatments such as micro-invasive glaucoma surgery, cochlear implantation, and biologic therapy for allergic rhinitis.

Differentiator

Problem solved

Functional benefit

Brands

• 同仁验光配镜: Optometry and glasses fitting services established in 1906, operating 18 direct stores in Beijing with over 400,000 annual examinations
• 同仁科技

Products and services

• Ophthalmology Services

Quantifiable outcome

• Blindness rate reduced from 1.4% to 0.5% over the past decade through intervention programs
• +2 more outcomes

Named customers3 records

Segments2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature4 records

Partnerships

Five partnerships are on record, tiered strategic and core.

• China UnicomstrategicTechnology or Integration · 1 January 2025Strategic partnership signed with China Unicom to co-develop smart healthcare and digital medical services, focusing on 5G applications, IoT connectivity, and intelligent hospital infrastructure.
• Beijing Economic and Technological Development ZonecoreStrategic or Co-development Partner · 1 January 2025Collaboration with Beijing Economic and Technological Development Zone to build a life health industry-education integration base (Tongren Science and Technology Innovation Center), focusing on joint research and technology transfer in life sciences.
• World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 2025WHO Ear and Hearing Health Cooperation Center designated at Beijing Tongren Hospital; Strategic planning meetings for WHO formal relationship organizations hosted by the hospital.
• National People's CongressstrategicStrategic or Co-development Partner · 1 January 2015Research cooperation between Capital Medical University General Surgery Department and Renji Hospital; Medical consortium with Xuanwu Hospital, Friendship Hospital, and Chaoyang Hospital under Capital Medical University.
• Australia Macquarie University Hearing ResearchstrategicStrategic or Co-development Partner · 1 January 2014First international joint hearing research center established at Tongren Hospital with Australian collaboration. Prof. Wang Shuo earned Master's in Clinical Audiology from Macquarie University.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Aier Eye Hospital Group: China's largest private ophthalmology specialty chain with a national network of hospitals and clinics. Most directly comparable peer in ophthalmology, differing mainly in private vs. public ownership and geographic scale.
• Zhongshan Ophthalmic Center (Sun Yat-sen University): Top-tier ophthalmology specialty hospital affiliated with Sun Yat-sen University in Guangzhou. Direct peer on ophthalmology specialty depth, academic leadership, and public tertiary hospital structure.

Broad incumbents

• Huashan Hospital (Fudan University): Major affiliated comprehensive tertiary hospital of Fudan University in Shanghai. Comparable in scale, public university affiliation, and national specialty reputation.
• Massachusetts Eye and Ear (Mass General Brigham): Harvard-affiliated U.S. specialty hospital combining ophthalmology and otolaryngology under one roof — directly parallel to Tongren's dual-specialty focus, useful as a global benchmark for clinical and research positioning.
• West China Hospital (Sichuan University): One of the largest public tertiary hospitals in China, affiliated with Sichuan University. Comparable in scale, teaching hospital status, and national ranking.
• Peking Union Medical College Hospital (PUMCH): China's flagship comprehensive tertiary public hospital under the Chinese Academy of Medical Sciences. Comparable as a top-tier Chinese public hospital with national referral standing, though broader in specialty mix.
• Wills Eye Hospital: U.S. specialty hospital exclusively dedicated to ophthalmology. Comparable in its deep specialization, academic affiliation, and historical brand strength in eye care.
• Moorfields Eye Hospital NHS Foundation Trust: World-leading UK ophthalmology specialty hospital with a long heritage and academic mission. Comparable as a globally recognized, ophthalmology-focused specialty institution with strong research output.

Emerging players

• Huaxia Eye Hospital Group: Mid-sized private ophthalmology chain in China. Comparable as a growing specialty competitor, though smaller in scale and brand than Aier.
• Beijing Tongren ENT-affiliated hospitals (e.g., PLA General Hospital Otolaryngology): Other major ENT specialty departments and centers in China (e.g., PLA 301 Hospital, Fudan Eye & ENT Hospital) that compete for ENT referrals and academic prestige, partially overlapping with Tongren's second key discipline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beijing Tongren Hospital, Capital Medical University